Get access to Dr. Reddys largest Cardiovascular API portfolios to support your formulation success.
Dr. Reddy's offers a wide selection of cardiovascular active pharmaceutical ingredients used in the production of formulations to treat cardiovascular diseases. Our portfolio includes a broad class of cardiovascular molecules: HMG–CoA reductase inhibitors (statins), adenosine triphosphate-citrate lyase (ACL) inhibitors, calcium channel blockers, angiotensin II receptor antagonists, anticoagulants, beta-blockers, lipid modifiers, and others.
Dr. Reddy's is well-positioned to meet the global demands of Cardiovascular APIs. As a Cardiovascular API manufacturer and supplier, we follow a multistage synthesis to ensure supply chain sustainability and compliance with global regulatory requirements. In addition, Dr. Reddy's has established solid strategic sourcing, logistics partnerships and works closely with our customers to successfully manage the capacities of our manufacturing units ahead of launches.
Look at Dr. Reddy's broad selection of active pharmaceutical ingredients cardiovascular drugs used to treat cardiovascular diseases like hypertension, angina, benign prostate hyperplasia, pulmonary arterial hypertension, heredity angioedema, and many more.
Anti-hypertensives
*Countries referred in the above graphic denotes DMF filing geographies
Anti-platelet
*Countries referred in the above graphic denotes DMF filing geographies
Anti-anemic
*Countries referred in the above graphic denotes DMF filing geographies
Anti-coagulants
*Countries referred in the above graphic denotes DMF filing geographies
Pulmonary arterial hypertension (PAH)
*Countries referred in the above graphic denotes DMF filing geographies
Lipid modifying agents
*Countries referred in the above graphic denotes DMF filing geographies
Anti-Angina
*Countries referred in the above graphic denotes DMF filing geographies
Hereditary Angioedema
*Countries referred in the above graphic denotes DMF filing geographies
Cardiovascular (transthyretin amyloidosis with polyneuropathy)
*Countries referred in the above graphic denotes DMF filing geographies
